TB-500 is being studied for muscle recovery and inflammation, but its lacking robust clinical evidence in humans
Moreover, the magnitude of this effect significantly depended on the dosage: median time to death, or ventilation support, was 570 days for placebo, 1,087 days for 25 mg, and 1,197 days for 50 mg methylcobalamin groups
Loren Pickart, who noticed that plasma from younger donors could make older liver tissue behave more youthfully in the lab
The combination regimen also decreased BAL protein levels, total cell number, and cell death
His research has been supported by the Department of Defense and the National Institutes of Health/National Cancer Institute (NCI)